Pharmexa files the first phase III application for inoperable patients with pancreatic cancer
03-Feb-2006 -
Pharmexa has now filed an application to the authorities in Ireland in order to obtain approval to initiate a phase III trial with GV1001 in inoperable patients with pancreatic cancer. Further pplications
are expected to be filed in the next two weeks in Sweden, Norway, the Netherlands, Australia ...
Belgium
Czech Republic
Denmark
+12